Physician profile
Eric Romain
NPI 1710341524
$2,770.35
in general payments reported to CMS, 2019-2025
8 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $244 · 2021: $299 · 2022: $131 · 2023: $769 · 2024: $563 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Travel and Lodging: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.19 |
| Travel and Lodging | $525.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,531.77 | 2021-2025 | Prostep, Augment Injectable, Infinity |
| Smith+Nephew, INC. | $677.60 | 2020-2023 | Grafix Pl, Grafix, Stravix Pl |
| Wright Medical Technology, INC. | $243.48 | 2019-2020 | |
| Medline Industries LP | $103.50 | 2025 | |
| Integra Lifesciences Corporation | $98.30 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $73.33 | 2025 | V.A.C.Instill |
| Zimmer Biomet Holdings, INC. | $25.75 | 2019 | |
| Depuy Synthes Sales INC. | $16.62 | 2025 | Motoband |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Romain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.